Canada markets closed

  • S&P/TSX
    19,999.59
    -144.45(-0.72%)

  • S&P 500
    4,166.45
    -55.41(-1.31%)

  • DOW
    33,290.08
    -533.37(-1.58%)

Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
353.70-4.08 (-1.14%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
3,041,440
2,923,933
2,621,226
2,266,096
1,857,601
Cost of Revenue
1,911,682
1,850,392
1,662,915
1,426,029
1,155,287
Gross Profit
1,129,758
1,073,541
958,311
840,067
702,314
Operating Expenses
Selling General and Administrative
554,767
528,935
517,622
443,854
373,446
Total Operating Expenses
667,607
640,812
607,160
508,684
414,816
Operating Income or Loss
462,151
432,729
351,151
331,383
287,498
Interest Expense
101,085
86,433
60,882
63,772
29,777
Total Other Income/Expenses Net
96,338
99,984
12,293
13,258
38,544
Income Before Tax
457,957
447,114
304,084
281,681
296,955
Income Tax Expense
79,553
81,808
50,023
54,463
171,369
Income from Continuing Operations
378,404
365,306
254,061
227,218
125,586
Net Income
375,065
364,304
252,019
226,373
123,355
Net Income available to common shareholders
375,065
364,304
252,019
226,373
123,355
Basic EPS
-
7.35
5.17
4.72
2.60
Diluted EPS
-
7.20
5.07
4.62
2.54
Basic Average Shares
-
49,550
48,730
47,947
47,481
Diluted Average Shares
-
50,611
49,693
49,018
48,564
EBITDA
-
768,471
563,061
507,232
457,891